Syra HealthSYRA
SYRA
About: Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health.
Employees: 162
0
Funds holding %
of 7,139 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
0% more funds holding
Funds holding: 13 [Q3] → 13 (+0) [Q4]
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
1.65% less ownership
Funds ownership: 7.87% [Q3] → 6.21% (-1.65%) [Q4]
24% less capital invested
Capital invested by funds: $299K [Q3] → $228K (-$70.8K) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for SYRA.
Financial journalist opinion
Neutral
PRNewsWire
3 days ago
Syra Health Announces Positive Preliminary Results from Syrenity Study Led by Indiana University
CARMEL, Ind. , Feb. 18, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today positive preliminary results from the clinical research study being conducted by Indiana University (IU) of its flagship mental health product, Syrenity.
Neutral
PRNewsWire
1 week ago
Syra Health Continues to Secure Healthcare Training Contracts
CARMEL, Ind. , Feb. 13, 2025 /PRNewswire/ -- Syra Health Corp. (Nasdaq: SYRA), a healthcare technology company powering better health by providing meaningful solutions, announced today that it has been awarded a six-month, $135,000 contract with a Midwest-based university to develop prevention-focused virtual training modules in behavioral health.
Neutral
PRNewsWire
1 month ago
Syra Health Wins New Workforce Contract, Announces Existing Contract Extension
CARMEL, Ind. , Jan. 7, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that the Washington D.C.
Neutral
PRNewsWire
2 months ago
Syra Health Launches Syrenity: An Evidence-Based App for Managing Common Mental Health Conditions
- Now Available for Download on the App Store and Google Play Store. CARMEL, Ind.
Neutral
PRNewsWire
2 months ago
Syra Health to Present at NobleCon20
CARMEL, Ind. , Nov. 26, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today its participation in the Noble Financial Capital Markets 20th Annual Equity Conference, known as NobleCon20, taking place December 3-4 in Boca Raton, Florida.
Neutral
PRNewsWire
3 months ago
Syra Health Delivers Third Quarter 2024 Financial Results
Achieved Net Revenue of $2.3 million, ~42% Growth Over the Prior Year Quarter Gross Margins Increased Following Shift in Operational Strategy Net Loss Narrowed to $417,535 ($0.06 per share), a Significant Improvement from the $1.39 million ($0.21 per share) Net Loss in Q2 of 2024 Aiming to Attain Profitability in 2025 through Targeted Revenue Growth and Cost-Efficiency Measures Conference call will be held today, Tuesday, October 29 th at 9:00 AM ET CARMEL, Ind. , Oct. 29, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), ("Syra Health" or the "Company") a healthcare technology company driving better health through impactful, innovative solutions, announced today its financial results for the third quarter ended September 30, 2024.
Neutral
PRNewsWire
4 months ago
Syra Health To Discuss Third Quarter 2024 Financial Results
Conference call will be held on Tuesday, October 29 at 9:00 AM ET CARMEL, Ind. , Oct. 22, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it will report financial results for the three months ended September 30, 2024, on Tuesday, October 29, 2024, before the market opens.
Neutral
PRNewsWire
4 months ago
Syra Health is Awarded New Healthcare Workforce Contracts Across Multiple States
CARMEL, Ind. , Oct. 9, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today more details about the award of three new healthcare workforce contracts: one in Florida, one in Kansas, and one in Delaware.
Neutral
PRNewsWire
4 months ago
Syra Health Marks First Anniversary as a Publicly Traded Company with Strong Successes and Growth
CARMEL, Ind. , Oct. 1, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, is celebrating its first anniversary as a publicly traded company and highlighting its many successes.
Neutral
PRNewsWire
5 months ago
Syra Health Announces Closing of $2.1 Million Public Offering
CARMEL, Ind. , Sept. 13, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, today announced the closing of its previously announced public offering of an aggregate of 3,203,125 shares of its Class A common stock, Series A warrants to purchase up to 3,203,125 shares of Class A common stock and Series B warrants to purchase up to 3,203,125 shares of Class A common stock (all the warrants, collectively, the "Series Warrants"), at a combined public offering price of $0.64 per share and accompanying Series Warrants.
Charts implemented using Lightweight Charts™